| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.2M | +1.8% | +26.3% |
| R&D Expense | $48.6M | +4.3% | -37.8% |
| SG&A Expense | $37.4M | -1.3% | -21.1% |
| Operating Income | -$125.3M | +21.1% | +31.7% |
| Pre-tax Income | -$118.7M | +22.3% | +31.1% |
| Income Tax | -$29.7M | +23.5% | +36.3% |
| Net Income | -$89.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $126.9M | -0.4% | -85.1% |
| Accounts Receivable | $16.3M | -0.2% | — |
| Current Assets | $589.4M | -9.6% | -35.2% |
| Total Assets | $2.60B | -3.8% | -16.6% |
| Current Liabilities | $77.4M | +9.6% | -17.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$235.2M | — | — |
| Capital Expenditures | $815K | — | — |
| Investing Cash Flow | $151.7M | — | — |
| Financing Cash Flow | $0 | — | — |
| Free Cash Flow | -$236.0M | — | — |
| +21.9% |
| +29.2% |
| EPS (Basic) | -$2.46 | +22.6% | +37.6% |
| EPS (Diluted) | -$2.46 | +22.6% | +37.6% |
| $361.1M |
| -6.9% |
| -31.9% |
| Stockholders' Equity | $2.24B | -3.2% | -13.4% |